Skip to main content
Erschienen in: Metabolic Brain Disease 4/2012

01.12.2012 | Original Paper

Gender and age effects on the continuous reaction times method in volunteers and patients with cirrhosis

verfasst von: Mette Munk Lauridsen, Henning Grønbæk, Esben B. Næser, Steffen T. Leth, Hendrik Vilstrup

Erschienen in: Metabolic Brain Disease | Ausgabe 4/2012

Einloggen, um Zugang zu erhalten

Abstract

Minimal hepatic encephalopathy (MHE) is a metabolic brain disorder occurring in patients with liver cirrhosis. MHE lessens a patient’s quality of life, but is treatable when identified. The continuous reaction times (CRT) method is used in screening for MHE. Gender and age effects on the CRT method are unknown and may confound the results. The aim of this study was to standardise the CRT method outcomes for age and gender effects. We studied 121 volunteers without known disease and 181 patients with cirrhosis by a CRT test. Reaction time to an auditory signal was measured 100 times, the 10th, 50th, and 90th reaction time percentiles were recorded, and the CRT index was calculated as the 50th percentile/(90th percentile-10th percentile), as a measure of intra-individual stability in reaction times. In volunteers, men reacted faster than women and their reaction times slowed with age. However, neither the gender nor the age effect was present regarding the CRT index. The patients with cirrhosis reacted slower and with a higher degree of instability than volunteers. Male patients reacted faster than female patients, and reaction times tended to slow with age. As among the volunteers, there was no gender or age effect on CRT index for the patients with cirrhosis. Age and gender influenced reaction times of both volunteers and patients with cirrhosis. The CRT index, however, was independent of age and gender in both groups. Screening of patients with cirrhosis using the CRT index, therefore, identifies brain dysfunction rather than effects of gender and age.
Literatur
Zurück zum Zitat Amodio P, Marchetti P, Del Piccolo F, Rizzo C, Iemmolo RM, Caregaro L, Gerunda G, Gatta A (1998) Study on the Sternberg paradigm in cirrhotic patients without overt hepatic encephalopathy. Metab Brain Dis 13(2):159–172PubMedCrossRef Amodio P, Marchetti P, Del Piccolo F, Rizzo C, Iemmolo RM, Caregaro L, Gerunda G, Gatta A (1998) Study on the Sternberg paradigm in cirrhotic patients without overt hepatic encephalopathy. Metab Brain Dis 13(2):159–172PubMedCrossRef
Zurück zum Zitat Amodio P, Del Piccolo F, Marchetti P, Angeli P, Iemmolo R, Caregaro L, Merkel C, Gerunda G, Gatta A (1999) Clinical features and survivial of cirrhotic patients with subclinical cognitive alterations detected by the number connection test and computerized psychometric tests. Hepatology 29(6):1662–1667. doi:10.1002/hep. 510290619 PubMedCrossRef Amodio P, Del Piccolo F, Marchetti P, Angeli P, Iemmolo R, Caregaro L, Merkel C, Gerunda G, Gatta A (1999) Clinical features and survivial of cirrhotic patients with subclinical cognitive alterations detected by the number connection test and computerized psychometric tests. Hepatology 29(6):1662–1667. doi:10.​1002/​hep.​ 510290619 PubMedCrossRef
Zurück zum Zitat Amodio P, Ridola L, Schiff S, Montagnese S, Pasquale C, Nardelli S, Pentassuglio I, Trezza M, Marzano C, Flaiban C, Angeli P, Cona G, Bisiacchi P, Gatta A, Riggio O (2010) Improving the inhibitory control task to detect minimal hepatic encephalopathy. Gastroenterology 139 (2):510-518, 518 e511-512. doi: 10.1053/j.gastro.2010.04.057 Amodio P, Ridola L, Schiff S, Montagnese S, Pasquale C, Nardelli S, Pentassuglio I, Trezza M, Marzano C, Flaiban C, Angeli P, Cona G, Bisiacchi P, Gatta A, Riggio O (2010) Improving the inhibitory control task to detect minimal hepatic encephalopathy. Gastroenterology 139 (2):510-518, 518 e511-512. doi: 10.​1053/​j.​gastro.​2010.​04.​057
Zurück zum Zitat Bajaj JS (2008) Minimal hepatic encephalopathy matters in daily life. World J Gastroenterol 14(23):3609–3615PubMedCrossRef Bajaj JS (2008) Minimal hepatic encephalopathy matters in daily life. World J Gastroenterol 14(23):3609–3615PubMedCrossRef
Zurück zum Zitat Bajaj JS, Saeian K, Verber MD, Hischke D, Hoffmann RG, Franco J, Varma RR, Rao SM (2007) Inhibitory control test is a simple method to diagnose minimal hepatic encephalopathy and predict development of overt hepatic encephalopathy. Am J Gastroenterol 102(4):754–760. doi:10.1111/j.1572-0241.2007.01048.x PubMedCrossRef Bajaj JS, Saeian K, Verber MD, Hischke D, Hoffmann RG, Franco J, Varma RR, Rao SM (2007) Inhibitory control test is a simple method to diagnose minimal hepatic encephalopathy and predict development of overt hepatic encephalopathy. Am J Gastroenterol 102(4):754–760. doi:10.​1111/​j.​1572-0241.​2007.​01048.​x PubMedCrossRef
Zurück zum Zitat Bajaj JS, Hafeezullah M, Franco J, Varma RR, Hoffmann RG, Knox JF, Hischke D, Hammeke TA, Pinkerton SD, Saeian K (2008) Inhibitory control test for the diagnosis of minimal hepatic encephalopathy. Gastroenterology 135 (5):1591-1600 e1591. doi: 10.1053/j.gastro.2008.07.021 Bajaj JS, Hafeezullah M, Franco J, Varma RR, Hoffmann RG, Knox JF, Hischke D, Hammeke TA, Pinkerton SD, Saeian K (2008) Inhibitory control test for the diagnosis of minimal hepatic encephalopathy. Gastroenterology 135 (5):1591-1600 e1591. doi: 10.​1053/​j.​gastro.​2008.​07.​021
Zurück zum Zitat Bajaj JS, Heuman DM, Wade JB, Gibson DP, Saeian K, Wegelin JA, Hafeezullah M, Bell DE, Sterling RK, Stravitz RT, Fuchs M, Luketic V, Sanyal AJ (2011) Rifaximin improves driving simulator performance in a randomized trial of patients with minimal hepatic encephalopathy. Gastroenterology 140 (2):478-487 e471. doi: 10.1053/j.gastro.2010.08.061 Bajaj JS, Heuman DM, Wade JB, Gibson DP, Saeian K, Wegelin JA, Hafeezullah M, Bell DE, Sterling RK, Stravitz RT, Fuchs M, Luketic V, Sanyal AJ (2011) Rifaximin improves driving simulator performance in a randomized trial of patients with minimal hepatic encephalopathy. Gastroenterology 140 (2):478-487 e471. doi: 10.​1053/​j.​gastro.​2010.​08.​061
Zurück zum Zitat Dhiman RK, Kurmi R, Thumburu KK, Venkataramarao SH, Agarwal R, Duseja A, Chawla Y (2010) Diagnosis and prognostic significance of minimal hepatic encephalopathy in patients with cirrhosis of liver. Dig Dis Sci 55(8):2381–2390. doi:10.1007/s10620-010-1249-7 PubMedCrossRef Dhiman RK, Kurmi R, Thumburu KK, Venkataramarao SH, Agarwal R, Duseja A, Chawla Y (2010) Diagnosis and prognostic significance of minimal hepatic encephalopathy in patients with cirrhosis of liver. Dig Dis Sci 55(8):2381–2390. doi:10.​1007/​s10620-010-1249-7 PubMedCrossRef
Zurück zum Zitat Elsass P (1984) Number Connection Test and Continuous Reaction Times in assesment of Organic and Metabolic Encephalopathy: A Comparative Study. Acta pharmacol et toxicol 54:115–119CrossRef Elsass P (1984) Number Connection Test and Continuous Reaction Times in assesment of Organic and Metabolic Encephalopathy: A Comparative Study. Acta pharmacol et toxicol 54:115–119CrossRef
Zurück zum Zitat Elsass P (1986) Continuous Reaction Times in cerebral dysfunction. Acta Neurologica Scandinavica 73:225–246PubMedCrossRef Elsass P (1986) Continuous Reaction Times in cerebral dysfunction. Acta Neurologica Scandinavica 73:225–246PubMedCrossRef
Zurück zum Zitat Elsass P, Hartelius H (1985) Reaction time and brain disease: relations to location, etiology and progression of cerebral dysfunction. Acta Neurol Scand 71(1):11–19PubMedCrossRef Elsass P, Hartelius H (1985) Reaction time and brain disease: relations to location, etiology and progression of cerebral dysfunction. Acta Neurol Scand 71(1):11–19PubMedCrossRef
Zurück zum Zitat Elsass P, Christensen SE, Ranek L, Theilgaard A, Tygstrup N (1981) Continuous reaction time in patients with hepatic encephalopathy. A quantitative measure of changes in consciousness. Scand J Gastroenterol 16(3):441–447PubMedCrossRef Elsass P, Christensen SE, Ranek L, Theilgaard A, Tygstrup N (1981) Continuous reaction time in patients with hepatic encephalopathy. A quantitative measure of changes in consciousness. Scand J Gastroenterol 16(3):441–447PubMedCrossRef
Zurück zum Zitat Elsass P, Christensen SE, Mortensen EL, Vilstrup H (1985) Discrimination between organic and hepatic encephalopathy by means of continuous reaction times. Liver 5(1):29–34PubMedCrossRef Elsass P, Christensen SE, Mortensen EL, Vilstrup H (1985) Discrimination between organic and hepatic encephalopathy by means of continuous reaction times. Liver 5(1):29–34PubMedCrossRef
Zurück zum Zitat Era P, Sainio P, Koskinen S, Ohlgren J, Harkanen T, Aromaa A (2011) Psychomotor speed in a random sample of 7,979 subjects aged 30 years and over. Aging Clin Exp Res 23(2):135–144. doi:7834 [pii] PubMed Era P, Sainio P, Koskinen S, Ohlgren J, Harkanen T, Aromaa A (2011) Psychomotor speed in a random sample of 7,979 subjects aged 30 years and over. Aging Clin Exp Res 23(2):135–144. doi:7834 [pii] PubMed
Zurück zum Zitat Fozard JL, Vercryssen M, Reynolds SL, Hancock PA, Quilter RE (1994) Age differences and changes in reaction time: the Baltimore Longitudinal Study of Aging. J Gerontol 49(4):P179–P189PubMed Fozard JL, Vercryssen M, Reynolds SL, Hancock PA, Quilter RE (1994) Age differences and changes in reaction time: the Baltimore Longitudinal Study of Aging. J Gerontol 49(4):P179–P189PubMed
Zurück zum Zitat Haussinger D, Schliess F, Kircheis G (2002) Pathogenesis of hepatic encephalopathy. J Gastroenterol Hepatol 17(Suppl 3):S256–S259PubMedCrossRef Haussinger D, Schliess F, Kircheis G (2002) Pathogenesis of hepatic encephalopathy. J Gastroenterol Hepatol 17(Suppl 3):S256–S259PubMedCrossRef
Zurück zum Zitat Lauridsen MM, Jepsen P, Vilstrup H (2011) Critical flicker frequency and continuous reaction times for the diagnosis of minimal hepatic encephalopathy: a comparative study of 154 patients with liver disease. Metab Brain Dis 26(2):135–139. doi:10.1007/s11011-011-9242-1 PubMedCrossRef Lauridsen MM, Jepsen P, Vilstrup H (2011) Critical flicker frequency and continuous reaction times for the diagnosis of minimal hepatic encephalopathy: a comparative study of 154 patients with liver disease. Metab Brain Dis 26(2):135–139. doi:10.​1007/​s11011-011-9242-1 PubMedCrossRef
Zurück zum Zitat Misra N, Mahajan KK, Maini BK (1985) Comparative study of visual and auditory reaction time of hands and feet in males and females. Indian J Physiol Pharmacol 29(4):213–218PubMed Misra N, Mahajan KK, Maini BK (1985) Comparative study of visual and auditory reaction time of hands and feet in males and females. Indian J Physiol Pharmacol 29(4):213–218PubMed
Zurück zum Zitat Prasad S, Dhiman RK, Duseja A, Chawla YK, Sharma A, Agarwal R (2007) Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy. Hepatology 45(3):549–559. doi:10.1002/hep. 21533 PubMedCrossRef Prasad S, Dhiman RK, Duseja A, Chawla YK, Sharma A, Agarwal R (2007) Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy. Hepatology 45(3):549–559. doi:10.​1002/​hep.​ 21533 PubMedCrossRef
Zurück zum Zitat Renzi D (1965) The comparative efficiency of intelligence and vigilance tests in detecting hemispheric cerebral damage. Cortex 1:410–433 Renzi D (1965) The comparative efficiency of intelligence and vigilance tests in detecting hemispheric cerebral damage. Cortex 1:410–433
Zurück zum Zitat Romero-Gomez M, Cordoba J, Jover R, del Olmo JA, Ramirez M, Rey R, de Madaria E, Montoliu C, Nunez D, Flavia M, Company L, Rodrigo JM, Felipo V (2007) Value of the critical flicker frequency in patients with minimal hepatic encephalopathy. Hepatology 45(4):879–885. doi:10.1002/hep. 21586 PubMedCrossRef Romero-Gomez M, Cordoba J, Jover R, del Olmo JA, Ramirez M, Rey R, de Madaria E, Montoliu C, Nunez D, Flavia M, Company L, Rodrigo JM, Felipo V (2007) Value of the critical flicker frequency in patients with minimal hepatic encephalopathy. Hepatology 45(4):879–885. doi:10.​1002/​hep.​ 21586 PubMedCrossRef
Zurück zum Zitat Schomerus H, Hamster W (2001) Quality of life in cirrhotics with minimal hepatic encephalopathy. Metab Brain Dis 16(1–2):37–41PubMedCrossRef Schomerus H, Hamster W (2001) Quality of life in cirrhotics with minimal hepatic encephalopathy. Metab Brain Dis 16(1–2):37–41PubMedCrossRef
Zurück zum Zitat Shukla S, Shukla A, Mehboob S, Guha S (2011) Meta-analysis: the effects of gut flora modulation using prebiotics, probiotics and synbiotics on minimal hepatic encephalopathy. Aliment Pharmacol Ther. doi:10.1111/j.1365-2036.2010.04574.x Shukla S, Shukla A, Mehboob S, Guha S (2011) Meta-analysis: the effects of gut flora modulation using prebiotics, probiotics and synbiotics on minimal hepatic encephalopathy. Aliment Pharmacol Ther. doi:10.​1111/​j.​1365-2036.​2010.​04574.​x
Zurück zum Zitat Sidhu SS, Goyal O, Mishra BP, Sood A, Chhina RS, Soni RK (2011) Rifaximin improves psychometric performance and health-related quality of life in patients with minimal hepatic encephalopathy (the RIME Trial). Am J Gastroenterol 106(2):307–316. doi:10.1038/ajg.2010.455 PubMedCrossRef Sidhu SS, Goyal O, Mishra BP, Sood A, Chhina RS, Soni RK (2011) Rifaximin improves psychometric performance and health-related quality of life in patients with minimal hepatic encephalopathy (the RIME Trial). Am J Gastroenterol 106(2):307–316. doi:10.​1038/​ajg.​2010.​455 PubMedCrossRef
Zurück zum Zitat Taberner PV (1980) Sex differences in the effects of low doses of ethanol on human reaction time. Psychopharmacology (Berl) 70(3):283–286CrossRef Taberner PV (1980) Sex differences in the effects of low doses of ethanol on human reaction time. Psychopharmacology (Berl) 70(3):283–286CrossRef
Metadaten
Titel
Gender and age effects on the continuous reaction times method in volunteers and patients with cirrhosis
verfasst von
Mette Munk Lauridsen
Henning Grønbæk
Esben B. Næser
Steffen T. Leth
Hendrik Vilstrup
Publikationsdatum
01.12.2012
Verlag
Springer US
Erschienen in
Metabolic Brain Disease / Ausgabe 4/2012
Print ISSN: 0885-7490
Elektronische ISSN: 1573-7365
DOI
https://doi.org/10.1007/s11011-012-9318-6

Weitere Artikel der Ausgabe 4/2012

Metabolic Brain Disease 4/2012 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.